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Positron (b+) emission tomography (PET) is a powerful,
noninvasive tool for the in vivo, three-dimensional imaging of
physiological structures and processes. PET imaging involves
the incorporation of short-lived radionuclides, particularly
carbon-11 and fluorine-18, into biologically active molecules.
The resulting radiopharmaceuticals are introduced into
human subjects, liberating positrons in the decay process that
subsequently annihilate with electrons in adjacent matter.
Detection of the g radiation generated during annihilation
allows for well-defined images of ongoing bodily processes to
be obtained. Understandably, wielding this technology—
which requires the manipulation of strong radioemitters,
short end-product efficacy timeframes, and rigorous quality
control—is not a simple undertaking. In answer to this, and
speaking to its clinical value, research pertaining to PET has
observed exciting and rapid growth.
The prospective applications for PET imaging are innu-
merable.[1] Exploiting PET to its fullest potential has been
limited, however, in large part, by the availability of pertinent
radiopharmaceuticals. The identification of a suitable radio-
nuclide for use in labeling is a concern intrinsic to the
preparation of radiopharmaceutical agents. Carbon-11 and
fluorine-18 are commonly used and each has its own merits.
Radiolabeling with 11C has advantages that include minimal
effects on substrate biological activity and ease of incorpo-
ration. 11C-radiolabeling also affords the ability to run multi-
ple scans per day in series. However, 11C suffers from a rather
short half-life (20 min) and susceptibility to environmental
12C contamination in processing.[2] 18F finds utility in light of
the fact that its incorporation into bioactive species some-
times affects their pharmacological profile. Fluorine-18 offers
the benefit of a substantial half-life (about 110 min, allowing
for distribution to satellite PET scan facilities), a clean decay
process (97% b+ emission) and limited positron migration
(about 1 mm, leading to highly resolved images). Indeed, 18F
is ubiquitous in molecular imaging by positron emission
tomography, as is exemplified by the success of [18F]2-fluoro-
2-deoxy-d-glucose (FDG) in oncology research.
[18F]Fluoride is prepared by the proton bombardment of
oxygen-18 enriched water through the nuclear reaction
18O(p,n)18F. Aqueous solutions of 18F are rendered, from
which the ion of interest can be isolated by ion-exchange
chromatography. Gaseous [18F]F2 is also available through the
nuclear reaction 20Ne(d,a)18F. The former facilitates nucleo-
philic fluorination reactions; the latter, electrophilic fluori-
nation. Both reaction modes have important applications in
PET imaging research. This article discusses recent strides in
the field of 18F radiochemistry, categorized by the reaction
motif.
Gouverneur and co-workers recently disclosed the prep-
aration of [18F]Selectfluor bis(triflate) 1 as a means to
broaden the scope and utility of electrophilic fluorination
for 18F radiochemistry.[3] Inspired by the mild, commercially
available fluorinating agent Selectfluor,[4] 1 was prepared
through chloromethylation of diazabicyclo[2.2.2]octane, an-
ion exchange, and subsequent fluorination using high-specific
activity [18F]F2 (Scheme 1). The resulting bis(triflate) was
shown to work effectively in contexts where conventional
[18F]F2 would generate complex reaction mixtures. Enolate
fluorination in the presence of an arene, for example, gave
only the desired a-fluoro-a-methyltetralone, in good yield
(Scheme 2). [18F]Selectfluor also proved readily reactive in
scenarios where other stable fluorinating agents (e.g., [18F]N-
fluorobenzenesulfonimide) were not, such as in the AgI-
mediated fluorodestannylation of electron-rich aromatic
substrates.
Until recently, stable electrophilic 18F fluorination re-
agents similar to 1 have exclusively been prepared using high-
specific activity [18F]F2. Ritter and co-workers have now
reported the preparation of the first electrophilic
18F fluorination reagent derived from a [18F]fluoride ion, 3
(Scheme 3).[5] Treatment of the in situ generated fluorophilic
palladium(IV) species 2 with [18F]KF affords 3. Following
filtration of 3 over a polymer-supported resin, PdII aryl
complexes such as estrone-derived 4 are introduced and
warmed at 85 8C for 10 min prior to processing. The two-step
Scheme 1. Synthesis of [18F]Selectfluor bis(triflate) 1.
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18F-labeling processes disclosed generally gave satisfactory
radiochemical yields of the target compounds (e.g., 5,
Scheme 3). The development of 3, given the practicality and
wider availability of [18F]F versus [18F]F2, provides the
radiochemist ready access to synthetically useful electrophilic
[18F]fluorine.
A number of reports describing improved methods and
substrates for nucleophilic fluorination have recently ap-
peared in the literature. Gouverneur and co-workers de-
scribed a protocol for palladium-catalyzed allylic fluorina-
tion[6] that well represents the adaptation of modern synthetic
methods for radiochemical synthesis. Allyl 4-nitrophenyl
carbonates were smoothly converted to their corresponding
allylic fluorides on treatment with TBAF·(tBuOH)4 in the
presence of catalytic Pd(dba)2 (TBAF= tetrabutylammonium
fluoride, dba= dibenzylideneacetone, Scheme 4). The meth-
od was then evaluated within the time constraints presented
by radionuclide handling. Nitrophenyl cinnamyl carbonate 6
gave the corresponding fluoride 7 in 7% radiochemical yield
(RCY); higher conversions (10–52% RCY) were observed
using methyl cinnamyl carbonate as substrate under pro-
longed reaction times (30 min). Satisfactory yields were also
obtained comparing the protocol to direct SN2
18F fluorination. Subjecting cinnamyl bromide to the system
for 5 min at room temperature gave 20% RCY of the
corresponding fluoride. Forcing conditions (110 8C, 20 min)
generated cinnamyl fluoride in 40 and 42% RCY from
cinnamyl chloride and bromide, respectively. Interestingly,
products of competitive SN2’ displacement, which are some-
times evident in direct substitution methods, were not
detected in the Pd-mediated variant.
Novel substrates for nucleophilic aromatic substitution
(SNAr) have recently been a topic of investigation relevant to
[18F] fluorination. Symmetric and asymmetric diaryliodonium
salts of target precursors, in particular, have received
attention owing to their ease of preparation and compatibility
with moderately electronic-rich arene systems.[7] For example,
Coenen and co-workers have disclosed aryl(2-thienyl)iodo-
nium salts as substrates of 18F for SNAr which show enhanced
reactivity at electron-rich homoarenes (Scheme 5a).[8] Sim-
ilarly, Pike and co-workers have shown the utility of diaryl-
iodonium tosylates in the synthesis of mGluR5 PET radio-
ligands (Scheme 5b).[9] Advances in this area have signifi-
cantly expanded the scope of classical SNAr beyond electron-
deficient arenes, to the benefit of 18F radiochemistry.
Direct incorporation of the 18F radionuclide by either
nucleophilic or electrophilic substitution is frequently em-
ployed for the preparation of radiopharmaceuticals. Sub-
strates that are not poised for direct 18F modification, how-
ever, are a common hindrance to the synthetic radiochemist.
Bimolecular reactions joining reactive 18F-labeled small
molecule prosthetic groups with a ligand of interest—or
Scheme 2. Synthetic applications of [18F]Selectfluor bis(triflate) 1.
Scheme 3. [18F]Fluoride-derived electrophilic fluorinating reagent, 3, for
PET imaging applications.
Scheme 4. Pd-catalyzed allylic [18F]fluorination reactions.
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“indirect 18F fluorination”—provide alternative means for
accessing radiopharmaceuticals.
[18F]Fluoroazides have found increasing utility as pro-
sthetic groups in 18F radiochemistry through the azide–alkyne
1,3-dipolar (Huisgen) cycloaddition.[10] Advances in the
Huisgen cycloaddition for PET increasingly have had to take
into account considerations of intellectual property and the
potential for cytotoxic transition-metal contamination in
clinic-bound radiotracers.[11] To circumvent the complications
presented by copper contamination, Feringa et al. recently
described applications of copper-free click chemistry pro-
moted by strained aza-cyclooctynyl species for
18F radiochemistry.[12] [18F]Azide 8 was incubated with aza-
cyclooctyne-modified bombesin 9 (Scheme 6) at ambient
temperature for 15 min (Scheme 5). A satisfactory radio-
chemical yield was observed in this first example of 18F-
radiolabeling through copper-free alkyne–azide [3+2] cyclo-
addition.
Other innovative [18F]fluorine-containing reagents for
radiopharmaceutical preparation have recently been dis-
closed. Cognizant that the trifluoromethyl is a privileged
motif in small molecule drugs, Riss and Aigbirhio reported a
technique for the synthesis of 1-[18F]fluoro-1,1-difluorometh-
yl groups.[13] A simple and efficient procedure for the
preparation of 2-[18F]fluoro-2,2-difluoroethyltosylate 11 was
outlined, beginning from the difluorovinylsulfonate 10
(Scheme 7). The resulting [18F]fluoroethylating agent proved
effective for O- and N-alkylation, giving rise to the neuro-
fibrillar tangle imaging agent 12 and the tropane derivative
13, respectively.
Gouverneur and co-workers recently showed that 4-
[18F]fluorobenzaldehydes are efficient vehicles for 18F deliv-
ery in classical multicomponent reactions.[14] Overcoming sub-
stoichiometric quantities of 4-[18F]fluorobenzaldehyde 14
versus other reaction participants and prolonged reaction
times witnessed in “cold” studies, radio-Groebke–Bienaym–
Blackburn reactions were successfully executed (Scheme 8).
Not illustrated here for the sake of brevity, Ugi, Passerini, and
Biginelli reactions were also carried out in good to excellent
radiochemical yields. Notably, the 3,4-dihydropyrimidin-2-
(1H)-ones, imidazo[1,2-a]pyridines and a-acyloxyamides ob-
tained by these methods featured 18F substituents not avail-
able by conventional direct SNAr techniques.
In answer to the increasing demand for novel radio-
pharmaceuticals, a number of research groups have initiated
programs directed toward the development of new radio-
labeling methods. This global effort has brought to bear an
impressive range of methods and reactions for
18F radiochemistry. The articles highlighted herein show
significant advances in direct electrophilic and nucleophilic
fluorination, as well as in the utility of radiolabeled prosthetic
groups.
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